Pressure measured with a cuff and sphygmomanometer in the brachial artery is accepted as
an important predictor of future cardiovascular risk. However, systolic pressure varies …

Background Beta‐blockers refer to a mixed group of drugs with diverse pharmacodynamic
and pharmacokinetic properties. They have shown long‐term beneficial effects on mortality …

The world population is aging and the number of old people is continuously increasing.
Arterial structure and function change with age, progressively leading to arterial stiffening …

Stroke is the second leading cause of mortality and morbidity worldwide. Early intervention
is of great importance in reducing disease burden. Since the conventional risk factors cannot …

Objective: To review the pharmacology, pharmacokinetics, and pharmacodynamic
properties of commonly used β-blockers (atenolol, carvedilol, metoprolol succinate …

Antihypertensive agents may, even within the same class, exert variable effects on arterial
stiffness variables. Nebivolol could have a better impact than atenolol on arterial stiffness, by …

Abstract Purpose of Review To describe the physiological aspects of blood pressure and
arterial stiffness, as well as explain how these processes are related. To review the available …

This MiniReview reports the current knowledge about the treatment of arterial hypertension
with the third‐generation beta‐adrenoceptor antagonist (BAA) nebivolol. Furthermore, it …

β-blockers are effective antihypertensive agents and, together with diuretics, have been the
cornerstone of pioneering studies showing their benefits on cardiovascular morbidity and …

Nebivolol, unlike other selective β1-receptor blockers, induces vasodilation attributable to
increased NO bioavailability. The relative contribution of this mechanism to the blood …